Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study, Parallel, Double-blind, Multicenter for Evaluation of Efficacy of Orlistat 60 mg as Adjuvant Treatment of Obesity in Adults

NCT01755676 is registered in ClinicalTrials.gov with EMS as lead sponsor.

NCT NCT01755676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01755676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study, Parallel, Double-blind, Multicenter for Evaluation of Efficacy of Orlistat 60 mg as Adjuvant Treatment of Obesity in Adults
Lead sponsor
EMS
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2016
Completion date
December 21, 2017
Enrollment
638 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

obesity